Oil and Gas - The Mother of Inflation - GineersNow Petroleum magazine

N E W S
S T O R I E S
The Harvard T. H. Chan School of Public Health
in the USA leads major genomic studies of
Lassa virus, Ebola virus, and Zika virus and
have carried out extensive work in virology and
microbial diagnostics, including contributions
to the development of innovative technologies.
“My lab has contributed to a range of fields
including human and microbial genomics,
information theory, and infectious disease
diagnostics and surveillance, while
developing new and cutting-edge diagnostic
and computational technologies for outbreak
prevention and response,” said Dr. Pardis
Sabeti, a Professor at the Center for Systems
Biology and Department of Organismic and
Evolutionary Biology at Harvard University, the
Harvard School of Public Health (HSPH), who
will direct the GVN Center. “Together with the
GVN, we can expand our study of pandemic
resilience in the future.”
The University of the West Indies (UWI) St.
Augustine in Trinidad and Tobago routinely
investigates a variety of important human
and animal pathogens vectored by mosquito,
tick, culicoides and bats including dengue,
Chikungunya, Zika and bat coronaviruses,
and will contribute to many of GVN’s initiatives.
UWI St. Augustine joins the GVN as an Affiliate
through GVN’s Center of Excellence in HIV and
HCV Clinical Pharmacology Laboratory, at the
University at Buffalo, SUNY, USA.
“We look forward to working with our GVN
collaborators, particularly at the University
at Buffalo, SUNY to share our expertise in
viral epidemiology research, as well as, to
participating in broader training programs to
enhance our virus research capacity,” said Dr.
Christine Carrington, Professor of Molecular
Genetics and Virology at UWI St. Augustine
and Director of the new GVN Affiliate.
Dr. Gene D. Morse, Distinguished Professor
and Director at the Center for Integrated
Global Biomedical Sciences at the University
at Buffalo, SUNY who leads the GVN Center
of Excellence said, “I am pleased to see my
colleagues from Trinidad and Tobago come
under the GVN umbrella. I look forward to
helping them share resources with the GVN,
test and develop antiviral therapies and
biomarkers, promote translational science and